Sign in
4

Changes in Ownership

Candel Therapeutics, Inc. Filed Acc 0001209191-22-060700

Chief Scientific Officer bought 1,238 shares at $1.61 ($1,993)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Barone Francesca Chief Scientific Officer 2022-12-08 Purchase +1,238 $1.61 $1,993 2,738 D
Open-market purchases · 1,238 sh · avg $1.61 · $1,993
Loading xslF345X03/doc4.xml…